Cingulate Inc.

CINGNASDAQHealthcare● Active

$4.53

+$0.04(+0.78%)

Market Cap$25395352

P/E Ratio—

52W High$11.89

52W Low$3.16

Avg Volume675K

Open$4.50

Beta-0.85

Insider Trades Ownership Employees

Cingulate Inc.（CING）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · CING · 截至 2026年6月9日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

∞

Buy/Sell (by trades)

整体情绪

偏多

↑ Buy 100%仅显示有效交易 · 排除RSU归属0% Sell ↓

Cingulate Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月9日

CING 季度内部人买卖趋势

CING 内幕交易卖出 · CING 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

1.7M840K0

2024 Q2

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 9, 2026

活跃内部人

近12个月交易最活跃 · CING CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

CING 高管卖出股份 · CING 董事内幕交易 · SEC Form 4申报

显示最近 20 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Feb 13, 2026	Hargroves Thomas Jeffrey Director	Purchase	97,276	$5.04	$490K	97,468	Form 4
Mar 9, 2026	Silva Raul R. EVP and CSO	Award	4,526	—	—	6,473	Form 4
Mar 9, 2026	Silva Raul R. EVP and CSO	Other	1,828	—	—	4,645	Form 4
Mar 9, 2026	Schaffer Shane J. CEO · Director	Award	6,862	—	—	7,035	Form 4
Mar 9, 2026	Schaffer Shane J. CEO · Director	Other	2,959	—	—	4,076	Form 4
Mar 9, 2026	Callahan Jennifer L. EVP and CFO	Award	15,329	—	—	20,388	Form 4
Mar 9, 2026	Callahan Jennifer L. EVP and CFO	Other	6,427	—	—	13,961	Form 4
Mar 9, 2026	Patel Nilay Dahyabhai EVP, CLO and CCO	Award	5,475	—	—	5,475	Form 4
Mar 9, 2026	Patel Nilay Dahyabhai EVP, CLO and CCO	Other	2,086	—	—	3,389	Form 4
Mar 9, 2026	Brams Matthew EVP and Chief Medical Officer	Award	4,526	—	—	9,182	Form 4
Mar 9, 2026	Brams Matthew EVP and Chief Medical Officer	Other	1,025	—	—	8,157	Form 4
Feb 6, 2026	Werth Peter J. Director	Purchase	19,455	$5.04	$98K	117,449	Form 4
Feb 6, 2026	Callahan Jennifer L. SVP and CFO	Purchase	4,864	$5.04	$25K	5,059	Form 4
Feb 6, 2026	Schaffer Shane J. CEO · Director	Purchase	6,809	$5.04	$34K	10,175	Form 4
Feb 6, 2026	Brams Matthew EVP and Chief Medical Officer	Purchase	1,946	$5.04	$10K	4,656	Form 4
Aug 15, 2024	Myers Laurie EVP and COO	Sale	202	$4.17	$841	0	Form 4
Apr 11, 2024	Werth Peter J. Director	Option	694,096	$0.00	$69	1,175,925	Form 4
Apr 11, 2024	Werth Peter J. Director	Option	341,912	$0.00	$684	481,829	Form 4
Mar 15, 2022	Callahan Jennifer L. SVP and CFO	Purchase	55	$27.10	$1K	2,333	Form 4
Sep 15, 2023	Callahan Jennifer L. Corporate Controller	Purchase	5,000	$0.67	$3K	45,508	Form 4

Hargroves Thomas Jeffrey

Director

Purchase

日期

Feb 13

股数

97,276

均价

$5.04

总金额

$490K

View Form 4 on SEC.gov

Silva Raul R.

EVP and CSO

Award

日期

Mar 9

股数

4,526

均价

—

总金额

—

View Form 4 on SEC.gov

Silva Raul R.

EVP and CSO

Other

日期

Mar 9

股数

1,828

均价

—

总金额

—

View Form 4 on SEC.gov

Schaffer Shane J.

CEO · Director

Award

日期

Mar 9

股数

6,862

均价

—

总金额

—

View Form 4 on SEC.gov

Schaffer Shane J.

CEO · Director

Other

日期

Mar 9

股数

2,959

均价

—

总金额

—

View Form 4 on SEC.gov

Callahan Jennifer L.

EVP and CFO

Award

日期

Mar 9

股数

15,329

均价

—

总金额

—

View Form 4 on SEC.gov

Callahan Jennifer L.

EVP and CFO

Other

日期

Mar 9

股数

6,427

均价

—

总金额

—

View Form 4 on SEC.gov

Patel Nilay Dahyabhai

EVP, CLO and CCO

Award

日期

Mar 9

股数

5,475

均价

—

总金额

—

View Form 4 on SEC.gov

Patel Nilay Dahyabhai

EVP, CLO and CCO

Other

日期

Mar 9

股数

2,086

均价

—

总金额

—

View Form 4 on SEC.gov

Brams Matthew

EVP and Chief Medical Officer

Award

日期

Mar 9

股数

4,526

均价

—

总金额

—

View Form 4 on SEC.gov

Brams Matthew

EVP and Chief Medical Officer

Other

日期

Mar 9

股数

1,025

均价

—

总金额

—

View Form 4 on SEC.gov

Werth Peter J.

Director

Purchase

日期

Feb 6

股数

19,455

均价

$5.04

总金额

$98K

View Form 4 on SEC.gov

Callahan Jennifer L.

SVP and CFO

Purchase

日期

Feb 6

股数

4,864

均价

$5.04

总金额

$25K

View Form 4 on SEC.gov

Schaffer Shane J.

CEO · Director

Purchase

日期

Feb 6

股数

6,809

均价

$5.04

总金额

$34K

View Form 4 on SEC.gov

Brams Matthew

EVP and Chief Medical Officer

Purchase

日期

Feb 6

股数

1,946

均价

$5.04

总金额

$10K

View Form 4 on SEC.gov

Myers Laurie

EVP and COO

Sale

日期

Aug 15

股数

202

均价

$4.17

总金额

$841

View Form 4 on SEC.gov

Werth Peter J.

Director

Option

日期

Apr 11

股数

694,096

均价

$0.00

总金额

$69

View Form 4 on SEC.gov

Werth Peter J.

Director

Option

日期

Apr 11

股数

341,912

均价

$0.00

总金额

$684

View Form 4 on SEC.gov

Callahan Jennifer L.

SVP and CFO

Purchase

日期

Mar 15

股数

均价

$27.10

总金额

$1K

View Form 4 on SEC.gov

Callahan Jennifer L.

Corporate Controller

Purchase

日期

Sep 15

股数

5,000

均价

$0.67

总金额

$3K

View Form 4 on SEC.gov

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 CING 内幕交易

CING 内幕交易

Cingulate Inc.（CING）内幕交易数据来源于公司内部人（包括Schaffer Shane J. (CEO · Director), Callahan Jennifer L. (EVP and CFO), Brams Matthew (EVP and Chief Medical Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。CING内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Cingulate Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

CING 内幕交易 · 5个问题

Cingulate Inc.（CING）的内部人包括高管和董事，如Schaffer Shane J. (CEO · Director), Callahan Jennifer L. (EVP and CFO), Brams Matthew (EVP and Chief Medical Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

CING 董事内幕交易CING 内部人名单Cingulate Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026